Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: hameln pharma limited, Nexus, Gloucester Business Park, Gloucester, GL3 4AG, United Kingdom
Neostigmine Methylsulfate Injection BP 2.5mg in 1ml.
| Pharmaceutical Form |
|---|
|
Sterile Injection. |
Each ml contains 2.5mg of Neostigmine Methylsulfate.
1 ampoule with 1 ml contains 2.5 mg Neostigmine Methylsulfate.
Excipients with known effect: This medicinal product contains approximately 3.54 mg sodium per each 1 ml ampoule – see section 4.4.
For a full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Neostigmine |
Neostigmine inhibits cholinesterase activity and prolongs and intensifies the muscarinic and nicotinic effects of acetylcholine. The anticholinesterase actions of neostigmine are reversible. It is used mainly for its action on skeletal muscle and less frequently to increase the activity of smooth muscle. |
| List of Excipients |
|---|
|
Sodium chloride |
1ml glass ampoules hermetically sealed under flame at the gauging point. The ampoules are packed in cartons to contain 10 ampoules.
hameln pharma limited, Nexus, Gloucester Business Park, Gloucester, GL3 4AG, United Kingdom
PL 01502/0023
5th February 1979 / 27th August 2001
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
